Clinical Trials Directory

Trials / Conditions / T-cell Childhood Acute Lymphoblastic Leukemia

T-cell Childhood Acute Lymphoblastic Leukemia

11 registered clinical trials studyying T-cell Childhood Acute Lymphoblastic Leukemia.

StatusTrialSponsorPhase
TerminatedGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T
NCT01088763
National Cancer Institute (NCI)Phase 1
CompletedBortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
NCT00873093
National Cancer Institute (NCI)Phase 2
CompletedDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01093586
Case Comprehensive Cancer CenterPhase 2
CompletedTacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patient
NCT00382109
Children's Oncology GroupPhase 3
TerminatedOxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or
NCT00101205
National Cancer Institute (NCI)Phase 1
CompletedResponse or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methot
NCT00898404
Children's Oncology Group—
CompletedAlemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
NCT00061945
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCombination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00049569
National Cancer Institute (NCI)N/A
CompletedBiological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leuke
NCT00052520
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
CompletedCombination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00016302
National Cancer Institute (NCI)N/A
Completed506U78 in Treating Patients With Refractory Hematologic Cancer
NCT00002970
National Cancer Institute (NCI)Phase 2